BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perelas A, Arrossi AV, Highland KB. Pulmonary Manifestations of Systemic Sclerosis and Mixed Connective Tissue Disease. Clin Chest Med 2019;40:501-18. [PMID: 31376887 DOI: 10.1016/j.ccm.2019.05.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Panagopoulos PK, Goules AV, Georgakopoulou VE, Kallianos A, Chatzinikita E, Pezoulas VC, Malagari K, Fotiadis DI, Vlachoyiannopoulos P, Vassilakopoulos T, Tzioufas AG. Small airways dysfunction in patients with systemic sclerosis and interstitial lung disease. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1016898] [Reference Citation Analysis]
2 Dupont A, Koether V, Labreuche J, Felloni P, Perez T, de Groote P, Remy J, Duhamel A, Hachulla E, Launay D, Remy-Jardin M. Dual-energy CT lung perfusion in systemic sclerosis: preliminary experience in 101 patients. Eur Radiol 2022. [PMID: 35881181 DOI: 10.1007/s00330-022-09016-7] [Reference Citation Analysis]
3 Maritati F, Provenzano M, Lerario S, Corradetti V, Bini C, Busutti M, Grandinetti V, Cuna V, La Manna G, Comai G. Kidney transplantation in systemic sclerosis: Advances in graft, disease, and patient outcome. Front Immunol 2022;13:878736. [DOI: 10.3389/fimmu.2022.878736] [Reference Citation Analysis]
4 Mormile I, Mormile M, Rea G, Petraroli A, Barbieri V, de Paulis A, Rossi FW. Spontaneous Pneumo-Mediastinum in a Post-COVID-19 Patient with Systemic Sclerosis. Healthcare 2022;10:529. [DOI: 10.3390/healthcare10030529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Clottu AS, Humbel M, Fluder N, Karampetsou MP, Comte D. Innate Lymphoid Cells in Autoimmune Diseases. Front Immunol 2021;12:789788. [PMID: 35069567 DOI: 10.3389/fimmu.2021.789788] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Krawczyk K, Mazur E, Kargol J, Kijowski R, Reich A. The Case of a Patient with Limited Systemic Sclerosis and Interstitial Lung Disease Overlapping with Systemic Lupus Erythematosus. Dermato 2021;1:59-70. [DOI: 10.3390/dermato1020009] [Reference Citation Analysis]
7 Tomassetti S, Colby TV, Wells AU, Poletti V, Costabel U, Matucci-Cerinic M. Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do? Ther Adv Musculoskelet Dis 2021;13:1759720X211059605. [PMID: 34900002 DOI: 10.1177/1759720X211059605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Koether V, Dupont A, Perez T, De Groote P, Labreuche J, Felloni P, Remy J, Remy-jardin M, Launay D. Le scanner double-énergie peut il détecter des anomalies de la circulation pulmonaire dans la sclérodermie systémique (SSc) ? Étude préliminaire sur 101 patients. La Revue de Médecine Interne 2021;42:A89. [DOI: 10.1016/j.revmed.2021.03.312] [Reference Citation Analysis]
9 Tapia LM, Pérez AA, Cuba JS, Sánchez-mateos ER. Protocolo diagnóstico diferencial de la afectación pulmonar en las enfermedades autoinmunes. Medicine - Programa de Formación Médica Continuada Acreditado 2021;13:1852-1855. [DOI: 10.1016/j.med.2021.04.015] [Reference Citation Analysis]
10 Koo BS, Park KY, Lee HJ, Kim HJ, Ahn HS, Yim SY, Jun JB. Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis. Arthritis Res Ther 2021;23:100. [PMID: 33823923 DOI: 10.1186/s13075-021-02494-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Innabi A, Gomez-Manjarres D, Alzghoul BN, Chizinga M, Mehrad B, Patel DC. Cyclophosphamide for the treatment of Acute Exacerbation of Interstitial Lung Disease: A Review of the Literature. Sarcoidosis Vasc Diffuse Lung Dis 2021;38:e2021002. [PMID: 33867789 DOI: 10.36141/svdld.v38i1.11271] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Minalyan A, Gabrielyan L, Khanal S, Basyal B, Derk C. Systemic Sclerosis: Current State and Survival After Lung Transplantation. Cureus 2021;13:e12797. [PMID: 33628666 DOI: 10.7759/cureus.12797] [Reference Citation Analysis]
13 Ananieva LP, Avdeev SN, Tyurin IЕ, Lila AМ, Zagrebneva AI, Maslyanskiy АL, Terpigorev SA, Stepanyan IV, Lashina EL, Vasilieva OV, Lukina OS, Pershina ES, Klimenko АА, Shostak NA, Nasonov EL. Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype. Naučno-praktičeskaâ revmatologiâ 2021;58:631-636. [DOI: 10.47360/1995-4484-2020-631-636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ahmed S, Gasparyan AY, Zimba O. Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic. Rheumatol Int 2021;41:243-56. [PMID: 33388969 DOI: 10.1007/s00296-020-04764-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 37.0] [Reference Citation Analysis]
15 Namvar L, Khabbazi A, Hasani S, Nazemiyeh M. Lack of association between six-minute walk distance and pulmonary artery pressure in patients with systemic sclerosis and cardiopulmonary symptoms. J Cardiovasc Thorac Res 2020;12:244-5. [PMID: 33123334 DOI: 10.34172/jcvtr.2020.42] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Perelas A, Silver RM, Arrossi AV, Highland KB. Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med 2020;8:304-20. [PMID: 32113575 DOI: 10.1016/S2213-2600(19)30480-1] [Cited by in Crossref: 97] [Cited by in F6Publishing: 106] [Article Influence: 48.5] [Reference Citation Analysis]
17 Tanaka Y, Kuwana M, Fujii T, Kameda H, Muro Y, Fujio K, Itoh Y, Yasuoka H, Fukaya S, Ashihara K, Hirano D, Ohmura K, Tabuchi Y, Hasegawa H, Matsumiya R, Shirai Y, Ogura T, Tsuchida Y, Ogawa-Momohara M, Narazaki H, Inoue Y, Miyagawa I, Nakano K, Hirata S, Mori M. 2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases. Mod Rheumatol 2021;31:29-33. [PMID: 31903831 DOI: 10.1080/14397595.2019.1709944] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]